These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32020034)

  • 1. Circulating serum HBsAg level is a biomarker for HBV-specific T and B cell responses in chronic hepatitis B patients.
    Kim JH; Ghosh A; Ayithan N; Romani S; Khanam A; Park JJ; Rijnbrand R; Tang L; Sofia MJ; Kottilil S; Moore CB; Poonia B
    Sci Rep; 2020 Feb; 10(1):1835. PubMed ID: 32020034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection.
    Le Bert N; Gill US; Hong M; Kunasegaran K; Tan DZM; Ahmad R; Cheng Y; Dutertre CA; Heinecke A; Rivino L; Tan A; Hansi NK; Zhang M; Xi S; Chong Y; Pflanz S; Newell EW; Kennedy PTF; Bertoletti A
    Gastroenterology; 2020 Aug; 159(2):652-664. PubMed ID: 32302614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis B.
    Le Bert N; Salimzadeh L; Gill US; Dutertre CA; Facchetti F; Tan A; Hung M; Novikov N; Lampertico P; Fletcher SP; Kennedy PTF; Bertoletti A
    J Hepatol; 2020 Jan; 72(1):34-44. PubMed ID: 31348999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating PD-1
    Zhang L; Li H; Ren H; Hu P
    Mol Immunol; 2018 Nov; 103():270-278. PubMed ID: 30340072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a novel IGRA assay to test T cell responsiveness to HBV antigens in whole blood of chronic Hepatitis B patients.
    Dammermann W; Bentzien F; Stiel EM; Kühne C; Ullrich S; Schulze Zur Wiesch J; Lüth S
    J Transl Med; 2015 May; 13():157. PubMed ID: 25968473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune correlates of hepatitis B surface antigen spontaneous seroconversion in hepatitis B e antigen negative chronic hepatitis B patients.
    Vyas AK; Sharma BC; Sarin SK; Trehanpati N
    Liver Int; 2018 Jan; 38(1):38-49. PubMed ID: 28500636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal characterization of phenotypic profile of T cells in chronic hepatitis B identifies immune markers associated with HBsAg loss.
    Xiong S; Zhu D; Liang B; Li M; Pan W; He J; Wang H; Sutter K; Dittmer U; Lu M; Liu D; Yang D; Liu J; Zheng X
    EBioMedicine; 2021 Jul; 69():103464. PubMed ID: 34233260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: A pilot study.
    Gane E; Verdon DJ; Brooks AE; Gaggar A; Nguyen AH; Subramanian GM; Schwabe C; Dunbar PR
    J Hepatol; 2019 Nov; 71(5):900-907. PubMed ID: 31306680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T- and B-cell responses and previous exposure to hepatitis B virus in 'anti-HBc alone' patients.
    Wang Q; Sachse P; Semmo M; Lokhande M; Montani M; Dufour JF; Zoulim F; Klenerman P; Semmo N
    J Viral Hepat; 2015 Dec; 22(12):1068-78. PubMed ID: 26075501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B core-specific memory B cell responses associate with clinical parameters in patients with chronic HBV.
    Vanwolleghem T; Groothuismink ZMA; Kreefft K; Hung M; Novikov N; Boonstra A
    J Hepatol; 2020 Jul; 73(1):52-61. PubMed ID: 32061650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels.
    Loggi E; Bihl FK; Cursaro C; Granieri C; Galli S; Brodosi L; Furlini G; Bernardi M; Brander C; Andreone P
    PLoS One; 2013; 8(6):e65327. PubMed ID: 23750252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of anti-HBs in functional cure of HBeAg+ chronic hepatitis B patients infected with HBV genotype A.
    Xu H; Locarnini S; Wong D; Hammond R; Colledge D; Soppe S; Huynh T; Shaw T; Thompson AJ; Revill PA; Hogarth PM; Wines BD; Walsh R; Warner N
    J Hepatol; 2022 Jan; 76(1):34-45. PubMed ID: 34371070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
    Akbar SM; Chen S; Al-Mahtab M; Abe M; Hiasa Y; Onji M
    Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
    Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
    Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
    Boni C; Janssen HLA; Rossi M; Yoon SK; Vecchi A; Barili V; Yoshida EM; Trinh H; Rodell TC; Laccabue D; Alfieri A; Brillo F; Fisicaro P; Acerbi G; Pedrazzi G; Andreone P; Cursaro C; Margotti M; Santoro R; Piazzolla V; Brunetto MR; Coco B; Cavallone D; Zhao Y; Joshi A; Woo J; Lau AH; Gaggar A; Subramanian GM; Massetto B; Fung S; Ahn SH; Ma X; Mangia A; Ferrari C
    Gastroenterology; 2019 Jul; 157(1):227-241.e7. PubMed ID: 30930022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward a Functional Cure for Hepatitis B: The Rationale and Challenges for Therapeutic Targeting of the B Cell Immune Response.
    Ma Z; Zhang E; Gao S; Xiong Y; Lu M
    Front Immunol; 2019; 10():2308. PubMed ID: 31608073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decades after recovery from hepatitis B and HBsAg clearance the CD8+ T cell response against HBV core is nearly undetectable.
    Kefalakes H; Jochum C; Hilgard G; Kahraman A; Bohrer AM; El Hindy N; Heinemann FM; Verheyen J; Gerken G; Roggendorf M; Timm J
    J Hepatol; 2015 Jul; 63(1):13-9. PubMed ID: 25646888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid-derived suppressor cells induce regulatory T cells in chronically HBV infected patients with high levels of hepatitis B surface antigen and persist after antiviral therapy.
    Pal S; Nandi M; Dey D; Chakraborty BC; Shil A; Ghosh S; Banerjee S; Santra A; Ahammed SKM; Chowdhury A; Datta S
    Aliment Pharmacol Ther; 2019 May; 49(10):1346-1359. PubMed ID: 30982998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of Core- and Polymerase-derived immunogenic peptides included in novel therapeutic vaccine by T cells from Chinese chronic hepatitis B patients.
    Huang D; Sansas B; Jiang JH; Gong QM; Jin GD; Calais V; Yu DM; Zhu MY; Wei D; Zhang DH; Inchauspé G; Zhang XX; Zhu R
    J Viral Hepat; 2017 Nov; 24 Suppl 1():66-74. PubMed ID: 29082648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential T-cell profiles determined by Hepatitis B surface antigen decrease among people with Human Immunodeficiency Virus /Hepatitis B Virus coinfection on treatment.
    Li X; Xu L; Lu L; Liu X; Yang Y; Wu Y; Zhu T; Li X; Li Y; Song X; Han Y; Lyu W; Cao W; Li T
    J Transl Med; 2024 Oct; 22(1):901. PubMed ID: 39367456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.